关注
Dita Gratzinger
Dita Gratzinger
在 stanford.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ...
Leukemia 36 (7), 1720-1748, 2022
17112022
Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2
A Ungewickell, A Bhaduri, E Rios, J Reuter, CS Lee, A Mah, A Zehnder, ...
Nature genetics 47 (9), 1056-1060, 2015
2822015
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
YH Kim, D Gratzinger, C Harrison, JD Brody, DK Czerwinski, WZ Ai, ...
Blood, The Journal of the American Society of Hematology 119 (2), 355-363, 2012
2242012
A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells.
MR Reinisch A, Thomas D, Corces MR, Zhang X, Gratzinger D, Hong WJ ...
Nature Medicine, 2016
2222016
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab
Y Natkunam, P Farinha, ED Hsi, CP Hans, R Tibshirani, LH Sehn, ...
Journal of Clinical Oncology 26 (3), 447-454, 2008
2092008
Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations
A Louissaint Jr, KT Schafernak, JT Geyer, AE Kovach, M Ghandi, ...
Blood, The Journal of the American Society of Hematology 128 (8), 1093-1100, 2016
1482016
Elevated glucose inhibits VEGF-A–mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2
JM Enciso, D Gratzinger, TD Camenisch, S Canosa, E Pinter, JA Madri
The Journal of cell biology 160 (4), 605-615, 2003
1242003
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy
D Gratzinger, S Zhao, RJ Tibshirani, ED Hsi, CP Hans, B Pohlman, M Bast, ...
Laboratory investigation 88 (1), 38-47, 2008
1172008
Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes
D Gratzinger, S Zhao, RJ Marinelli, AV Kapp, RJ Tibshirani, AS Hammer, ...
The American journal of pathology 170 (4), 1362-1369, 2007
1102007
Platelet endothelial cell adhesion molecule‐1 modulates endothelial cell motility through the small G‐protein Rho
D Gratzinger, S Canosa, B Engelhardt, JA Maori
The FASEB journal 17 (11), 1458-1469, 2003
1062003
EBV-positive B-cell proliferations of varied malignant potential: 2015 SH/EAHP workshop report—part 1
Y Natkunam, JR Goodlad, A Chadburn, D de Jong, D Gratzinger, ...
American journal of clinical pathology 147 (2), 129-152, 2017
992017
Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?
Y Natkunam, D Gratzinger, A Chadburn, JR Goodlad, JKC Chan, J Said, ...
Blood, The Journal of the American Society of Hematology 132 (18), 1871-1878, 2018
972018
Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow
E Flores-Figueroa, S Varma, K Montgomery, PL Greenberg, D Gratzinger
Laboratory investigation 92 (9), 1330-1341, 2012
972012
Magnetic resonance imaging of tumor-associated macrophages: clinical translation
M Aghighi, AJ Theruvath, A Pareek, LL Pisani, R Alford, AM Muehe, ...
Clinical Cancer Research 24 (17), 4110-4118, 2018
912018
HHV8/KSHV-positive lymphoproliferative disorders and the spectrum of plasmablastic and plasma cell neoplasms: 2015 SH/EAHP workshop report—part 3
A Chadburn, J Said, D Gratzinger, JKC Chan, D de Jong, ES Jaffe, ...
American Journal of Clinical Pathology 147 (2), 171-187, 2017
812017
Bone marrow histomorphological criteria can accurately diagnose hemophagocytic lymphohistiocytosis
E Gars, N Purington, G Scott, K Chisholm, D Gratzinger, BA Martin, ...
Haematologica 103 (10), 1635, 2018
742018
Platelet–endothelial cell adhesion molecule-1 modulates endothelial migration through its immunoreceptor tyrosine-based inhibitory motif
D Gratzinger, M Barreuther, JA Madri
Biochemical and biophysical research communications 301 (1), 243-249, 2003
712003
KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study
RT Swords, PL Greenberg, AH Wei, S Durrant, AS Advani, MS Hertzberg, ...
Leukemia research 50, 123-131, 2016
642016
Entrustable professional activities for pathology: recommendations from the College of American Pathologists Graduate Medical Education Committee
CB McCloskey, RE Domen, RM Conran, RD Hoffman, MD Post, ...
Academic pathology 4, 2374289517714283, 2017
622017
Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R‐CHOP)
D Gratzinger, R Advani, S Zhao, N Talreja, RJ Tibshirani, R Shyam, ...
British journal of haematology 148 (2), 235-244, 2010
572010
系统目前无法执行此操作,请稍后再试。
文章 1–20